skip to main content
Give

E. Paul Holder

E. Paul Holder
E. Paul Holder, PharmD

Instructional Associate Professor of Pharmacy Practice

Contact

Texas A&M Irma Lerma Rangel College of Pharmacy
Mail Stop 1114, 159 Reynolds Medical Building
College Station, TX 77843
holder@tamu.edu
Phone: 979.436.0596
Fax: 979.436.0087

Education and Training

  • Texas A&M Health Science Center, Scott & White Memorial Hospital and The University of Texas at Austin/The University of Texas Health Science Center in San Antonio, Specialty Residency, Drug Information Practice, 1995
  • The University of Texas at Austin/The University of Texas Health Science Center in San Antonio, Doctor of Pharmacy, 1994
  • The University of Texas at Austin, Bachelor of Science in Pharmacy (with High Honors), 1991
  • Sam Houston State University, Master of Science in Theoretical Physical Chemistry (Summa Cum Laude), 1981
  • Sam Houston State University, Bachelor of Science in Chemistry (Magna Cum Laude), 1979
  • Baylor University, Department of Chemistry, High Pressure Studies of Macromolecular Solutions – Supervising Professor Dr. Stig Claesson, former Chair of Nobel Selection Committee for Chemistry and Physics
  • Texas A&M University, Department of Chemistry, Glass Transition Point Studies of Cross-linked Bisphenolacetone Copolymers – Supervising Professor Dr. C.A.J. Hoeve

Research Interests

  • Federal and State Pharmacy Law
  • Preceptor Education
  • International Comparative Pharmacy Education

Teaching Interests

  • Pharmacy Law
  • Sterile Preparations
  • Pharmacy Compounding
  • Basic and Clinical Pharmacokinetics
  • Pharmacy Calculations

Awards, Recognition and Service

  • Item Writer, NABP Multi-State Jurisprudence Exam (MPJE) (2005 to 2014)
  • Item Writer, NABP Pharmacy Licensing Exam (NAPLEX) (1997)
  • Member, Pharmacy Technician Certification Board Task Force on Advanced Credentialing in Sterile Compounding (2015 - )
  • Member, Pharmacy Technician Certification Board Thought Leaders for C.R.E.S.T. (Consumer Awareness, Resources, Education, State Policy, and Testing) Summit (2011)
  • Knighthood By Mandate of Pope Benedict XVI – Invested into the Equestrian Order of the Holy Sepulchre of Jerusalem and awarded the title of Knight of the Holy Sepulchre, styled as Sir Paul Holder, KHS
  • Fellow – Texas Society of Health-System Pharmacists (2015)
  • Rho Chi Society (1989)
  • Who’s Who in Medicine and Health Care, Inaugural Edition (1997-98)
  • Who’s Who in the World (1996)
  • Who’s Who in the South and Southwest (1995, 1997)
  • Men of Achievement (1996)
  • Who’s Who Among Students in American Universities and Colleges (1979)
  • International Youth in Achievement
  • Community Leaders of America - Young Community Leadership Award
  • Alpha Chi, Phi Theta Kappa, and Golden Key National Honor Society

Patents

  • Edmondson JG and Holder EP. Inhibitor treatment program for chlorine dioxide corrosion. US Patent No. 5,064,612 (1991)
  • Edmondson JG and Holder EP. Inhibitor treatment program for chlorine dioxide corrosion. US Patent No. 4,994,195 (1991).
  • Brown JM, Holder EP, and Sherwood SP. Method of controlling manganese deposition in open recirculating aqueous systems. US Patent No. 4,900,451 (1990).
  • Holder EP, Klaessig FC, Peerce-Landers PJ, et.al. Method and compositions for penetrating and removing accumulated corrosion products and deposits from metal surfaces. US Patent No. 4,789,406 (1988).

Memberships

  • Texas Society of Health-System Pharmacists Journal, Editor/Chair of Editorial Board October 2017 to present.
  • Journal of Clinical Pharmacology and Toxicology, Member, November 2015 to present.
  • Annals of Pharmacology and Pharmaceutics, Member, August 2016 to present.

Representative Publications

Book Chapters

  • Holder, E. Paul Chapter H: “Compounding Laws and Rules.”  Texas and Federal Pharmacy and Drug Law. Fred S. Brinkley, Jr. and Gary G. Cacciatore. Pharmacy Regulatory Advisors, 2018, 2019.
  • Vega, J.A., Ochoa, P.S., Holder, P, “Chapter 1. Introduction to Parenteral Preparations.” In “Concepts in Parenteral Preparations and Aseptic Technique, 1-16. Burlington, MA: Jones and Bartlett Learning, 2015.  ISBN-13 #9781284035728

 Book Reviews

Scholar EM, Pratt WB.  The Antimicrobial Drugs 2nd Ed.  Oxford University Press, Oxford, England, 2000.  Ann. Pharmacother 2001;35(4):509.

Selected Articles

  • Holder EP.  291.133 New Sterile Compounding Rules.  Texas State Board of Pharmacy Newsletter (Fall 2007).
  • Parker S, Herrington J, Holder P.  Assessing piperacillin/tazobactam (Zosyn). Drug Util Rev 1999;15(12):S1-S3.
  • Holder EP, Moore PT, Browne BA.  Nonsteroidal antiinflammatory drugs and necrotizing fasciitis--An update.  Drug Safety, 1997;17:369-73 (invited publication).
  • Browne BA, Holder EP, Rupnick L.  No basis for associating nonprescription ibuprofen and similar agents with necrotizing fasciitis, Authors response.  Am J Health-Syst Pharm1996;53:2218-9.
  • Browne BA, Holder EP, Rupnick L.  NSAIDs and necrotizing fasciitis.  Am J Health-Syst Pharm 1996;53:265-269.

 Invited International Presentations

  • Education and Training of Clinical Pharmacists in the United States.  Presented to the Department of Pharmacy, National University of Singapore, Singapore (May 1998)
  • Klinische Pharmazie in den Vereinigten Staaten (Clinical Pharmacy in the United States).  Presented to the Wiener Krankenanstaltenverbundes at Allgemeines Krankenhaus, Vienna, Austria  (July 1997)
  • Klinische Apotheke Belehrung in den Vereinigten Staaten (Clinical Pharmacy Education in the United States).  Presented to the Department of Pharmacology, Universität Wien (The University of Vienna), Vienna, Austria.  (July 1997)
  • Apoteken Praktizieren in den Vereinigten Staaten--Damals und Heute  (Pharmacy Practice in the United States--Then and Now).  Presented to the Institute of Pharmaceutical Chemistry, Universität Wien (The University of Vienna), Vienna, Austria.  (July 1997)
  • Re-engineering the Therapeutic Drug Monitoring Program.  Presented with Paul Godley, Pharm.D., FASHP at the Fourth International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Vienna, Austria.  (September 1995)